Possible ameliorating effects of erythroblastosis by promethazine hydrochloride.
D000818:Animals; D001722:Birth Order; D001805:Blood Transfusion, Intrauterine; D003165:Complement System Proteins / Q000032:analysis; D003298:Coombs Test; D004899:Erythroblastosis, Fetal / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D005315:Fetal Diseases / Q000188:drug therapy; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D010973:Platelet Adhesiveness / Q000187:drug effects; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011296:Prenatal Diagnosis; D011398:Promethazine / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D011919:Rats, Inbred Strains
D003165:Complement System Proteins; D011398:Promethazine